Urogen Pharma Ltd. · NASDAQ:URGN
Schoenberg Mark sold 10,000 Urogen Pharma Ltd. shares (Form 4)
Traded Jun 22, 2026 · Filed Jun 24, 2026
On Jun 22, 2026, Schoenberg Mark (Chief Medical Officer) sold 10,000 Urogen Pharma Ltd. shares at US$35.01 for US$350K under a trading plan, leaving 129,763 shares. Filed Jun 24, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$35.01
- Value
- US$350K
- Holding after
- 129,763 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Ordinary Shares | Sale | 10,000 | US$35.01 | 129,763 | Direct |
Source
Related
- Urogen Pharma Ltd.
- Schoenberg Mark
- Urogen Pharma Ltd. shareholders
- Form 4 · Schoenberg Mark · Sep 9, 2026
- Form 4 · Schoenberg Mark · Aug 24, 2026
- Form 4 · Schoenberg Mark · Jul 10, 2026
- Form 4 · Schoenberg Mark · Jun 9, 2026
- Form 4 · Schoenberg Mark · May 11, 2026
- Form 4 · Degnan Chris · Oct 9, 2026
- Form 4 · Smith Jason Drew · Sep 9, 2026
- Form 4 · Robinson James A. Jr. · Aug 28, 2026
- Form 4 · Robinson James A. Jr. · May 27, 2026